Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Córdoba
Clinical trial register · Spain

Clinical Trials in Córdoba, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 111 Madrid 100 Valencia 42 Santiago Compostela 30 Seville 30
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca40 Novartis Pharmaceuticals22 Maimónides Biomedical Research Institute of Córdoba16 AbbVie16 Janssen Research & Development, LLC15 Clear sponsor filter
Site location
Barcelona111 Madrid100 Valencia42 Santiago Compostela30 Seville30
All 75 locations
Target enrolment
to

Trials with a site in Córdoba

22 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Novartis Pharmaceuticals
Observational
35
Córdoba, Madrid
2026-09-22
Recruiting
Remibrutinib Open Label Roll-over Post-trial Access Protocol
NCT07456891Indication of the Parent Protocol
DrugRemibrutinib
Novartis Pharmaceuticals
Phase 3
648
Barcelona, Alicante, Córdoba, Madrid, Valencia
2026-04-16
Recruiting
Novartis Pharmaceuticals
Phase 2
272
Santiago Compostela, Sant Cugat Del V, Burjassot, Córdoba
2026-03-09
Recruiting
Novartis Pharmaceuticals
Phase 2
210
Santiago de Compostela, Barcelona, Córdoba, Madrid, Pontevedra, Seville
2026-03-09
Active, closed
Novartis Pharmaceuticals
Phase 2
168
Santander, Badajoz, Lugo, Barcelona, Córdoba
2025-07-07
Recruiting
Novartis Pharmaceuticals
Phase 3
400
El Palmar, Valencia, Barcelona, Córdoba, Madrid, Málaga, Seville
2025-06-23
Active, closed
Novartis Pharmaceuticals
Phase 3
246
Santiago Compostela, Pamplona, Castilleja de la Cuesta, A Coruña, Barcelona, Córdoba, Huelva, Las Palmas GC
2025-04-30
Active, closed
Novartis Pharmaceuticals
Phase 1/2
28
Barcelona, Córdoba, Madrid, Valencia
2025-02-24
Active, closed
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
NCT06665256Idiopathic Inflammatory Myopathies
DrugRapcabtagene autoleucel
Novartis Pharmaceuticals
Phase 2
21
Santiago Compostela, Santander, Pamplona, Barcelona, Córdoba, Madrid, Málaga, Salamanca
2024-12-17
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Santiago Compostela, Santander, Pamplona, Barcelona, Córdoba, Madrid, Málaga, Salamanca
2024-10-29
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Santiago Compostela, Santander, Pamplona, Barcelona, Córdoba, Madrid, Salamanca, Valencia
2024-09-04
Recruiting
Novartis Pharmaceuticals
Phase 2
502
Cáceres, Córdoba, Madrid, Salamanca, Valencia
2024-03-07
Recruiting
Novartis Pharmaceuticals
Phase 3
50
Santiago Compostela, Barcelona, Córdoba, Málaga, Seville, Valencia
2024-02-28
Active, closed
Novartis Pharmaceuticals
Phase 3
470
Granada, Barcelona, Córdoba, Las Palmas GC, Valencia
2023-11-15
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Badalona, Sabadell, Bilbao, Santander, Vigo, A Coruña, Barcelona, Córdoba
2023-10-27
Active, closed
Novartis Pharmaceuticals
Phase 3
109
Santiago Compostela, L'Hospitalet de Llobregat, Santander, El Palmar, Barcelona, Córdoba, Madrid, Salamanca
2023-10-02
Recruiting
Novartis Pharmaceuticals
Phase 3
200
Esplugues, Sabadell, Barcelona, Córdoba, Madrid, Málaga
2023-05-11
Recruiting
Novartis Pharmaceuticals
Phase 3
195
Pamplona, Oviedo, A Coruña, Córdoba
2023-02-10
Active, closed
Novartis Pharmaceuticals
Phase 3
506
Santander, Vigo, Barcelona, Córdoba, Madrid, Valencia
2022-08-04
Active, closed
Novartis Pharmaceuticals
Phase 3
610
A Coruña, Barcelona, Córdoba, Madrid, Salamanca, Valencia
2022-07-08
Active, closed
Novartis Pharmaceuticals
Phase 3
95
Pamplona, Oviedo, Córdoba, Madrid
2022-06-15
Active, closed
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
NCT03960840Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia
DrugIbrutinib
Novartis Pharmaceuticals
Phase 1/2
217
Badalona, L'Hospitalet de Llobregat, Barcelona, Córdoba, Madrid, Salamanca, Seville, Valencia
2019-06-26
Rows per page Showing 1–22 of 22
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/c-rdoba

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 22 of those studies with a site in Córdoba that also match the filters currently applied.

How many clinical trials are recruiting in Córdoba?

9 of the 22 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 13 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Córdoba), 22 studies
PhaseStudiesRecruitingShare
Phase 312554.5%
Phase 27331.8%
Phase 1/2209.1%
Observational114.5%

Most active sponsors

Lead sponsors with the most studies (Córdoba)
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals229
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.